{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:11:16Z","timestamp":1787238676814,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/17213-2"],"award-info":[{"award-number":["2015\/17213-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006506","name":"Minist\u00e9rio da Sa\u00fade","doi-asserted-by":"publisher","award":["01060010.00RS"],"award-info":[{"award-number":["01060010.00RS"]}],"id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007374","name":"Universidade Federal de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.eprac.2025.07.023","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:55:02Z","timestamp":1754441702000},"page":"135-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lower Serum Triiodothyronine Levels Constitute an Independent Risk Factor for Dyslipidemia in Levothyroxin-Treated Patients"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2125-7051","authenticated-orcid":false,"given":"Gustavo C.","family":"Penna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel O.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela J.M.","family":"Bensenor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ettleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda C.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C.","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.eprac.2025.07.023_bib1","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1210\/clinem\/dgae139","article-title":"Thyroid hormone homeostasis in levothyroxine-treated patients: findings from ELSA-Brasil","volume":"109","author":"Penna","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.07.023_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/EJE-11-1029","article-title":"TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy","volume":"167","author":"Ito","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.eprac.2025.07.023_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM197403072901001","article-title":"Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation","volume":"290","author":"Stock","year":"1974","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.eprac.2025.07.023_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022552","article-title":"Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients","volume":"6","author":"Gullo","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.eprac.2025.07.023_bib5","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad155","article-title":"Sustained pituitary T3 production explains the T4-mediated TSH feedback mechanism","volume":"164","author":"Batistuzzo","year":"2023","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.023_bib6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1172\/JCI77588","article-title":"Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine","volume":"125","author":"Werneck de Castro","year":"2015","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.eprac.2025.07.023_bib7","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1210\/jc.2016-2660","article-title":"Is a normal TSH synonymous with \"euthyroidism\" in levothyroxine monotherapy?","volume":"101","author":"Peterson","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2025.07.023_bib8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1530\/eje.1.02025","article-title":"Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism","volume":"153","author":"Wekking","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2025.07.023_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/EJE-15-0395","article-title":"Quality of life in patients with primary hypothyroidism related to BMI","volume":"173","author":"Kelderman-Bolk","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2025.07.023_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/cen.13101","article-title":"Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer","volume":"85","author":"Massolt","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.023_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3181\/00379727-143-37364","article-title":"Effect of thyroidectomy on conversion of cholesterol into bile acids","volume":"143","author":"Byers","year":"1973","journal-title":"Proc Soc Exp Biol Med"},{"issue":"10101","key":"10.1016\/j.eprac.2025.07.023_bib12","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","article-title":"Hypothyroidism","volume":"390","author":"Chaker","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.eprac.2025.07.023_bib13","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1210\/jc.2005-1833","article-title":"Mortality and vascular outcomes in patients treated for thyroid dysfunction","volume":"91","author":"Flynn","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2025.07.023_bib14","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/jcm8081106","article-title":"Association between thyroid-stimulating hormone level after total thyroidectomy and hypercholesterolemia in female patients with differentiated thyroid cancer: a retrospective study","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.eprac.2025.07.023_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1089\/thy.2016.0426","article-title":"Biochemical markers reflecting thyroid function in athyreotic patients on levothyroxine monotherapy","volume":"27","author":"Ito","year":"2017","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.eprac.2025.07.023_bib16","first-page":"4533","article-title":"Systemic thyroid hormone status during levothyroxine therapy in hypothyroidism: a systematic review and meta-analysis","volume":"103","author":"McAninch","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2025.07.023_bib17","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab038","article-title":"Use of statins among patients taking levothyroxine: an observational drug utilization study across sites","volume":"5","author":"Idrees","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.eprac.2025.07.023_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1044691","article-title":"T3 levels and thyroid hormone signaling","volume":"13","author":"Salas-Lucia","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.eprac.2025.07.023_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/aje\/kwr294","article-title":"Brazilian longitudinal study of adult health (ELSA-Brasil): objectives and design","volume":"175","author":"Aquino","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.eprac.2025.07.023_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ije\/dyu027","article-title":"Cohort profile: longitudinal study of adult health (ELSA-Brasil)","volume":"44","author":"Schmidt","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.eprac.2025.07.023_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1590\/S1516-31802010000100005","article-title":"Frequency of subclinical thyroid dysfunction and risk factors for cardiovascular disease among women at a workplace","volume":"128","author":"Diaz-Olmos","year":"2010","journal-title":"Sao Paulo Med J"},{"issue":"1","key":"10.1016\/j.eprac.2025.07.023_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1590\/S0102-311X2011000100016","article-title":"Prevalence of thyroid disorders among older people: results from the S\u00e3o Paulo Ageing & Health Study","volume":"27","author":"Bense\u00f1or","year":"2011","journal-title":"Cad Saude Publica"},{"issue":"6","key":"10.1016\/j.eprac.2025.07.023_bib23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2265.2007.02816.x","article-title":"Low prevalence of hypothyroidism among Black and Mulatto people in a population-based study of Brazilian women","volume":"66","author":"Sichieri","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2025.07.023_bib24","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20198417","article-title":"Thyroid disorders in Brazil: the contribution of the Brazilian longitudinal study of adult health (ELSA-Brasil)","volume":"52","author":"Bensenor","year":"2019","journal-title":"Braz J Med Biol Res"},{"issue":"Suppl 2","key":"10.1016\/j.eprac.2025.07.023_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2025.07.023_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117312","article-title":"Non-HDL-cholesterol in dyslipidemia: review of the state-of-the-art literature and outlook","volume":"383","author":"Raja","year":"2023","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.eprac.2025.07.023_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12872-016-0450-9","article-title":"Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? A retrospective study","volume":"17","author":"Wongcharoen","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"10215","key":"10.1016\/j.eprac.2025.07.023_bib28","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(19)32519-X","article-title":"Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium","volume":"394","author":"Brunner","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.eprac.2025.07.023_bib29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.amjcard.2015.06.040","article-title":"Usefulness of low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol as predictors of cardiovascular disease in Chinese","volume":"116","author":"Gu","year":"2015","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.eprac.2025.07.023_bib30","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.amjcard.2017.01.008","article-title":"Usefulness of non-high-density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men in 22-Year follow-up","volume":"119","author":"Harari","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.eprac.2025.07.023_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/ENDO:24:1:001","article-title":"Hypothyroidism as a risk factor for cardiovascular disease","volume":"24","author":"Biondi","year":"2004","journal-title":"Endocr Pract"},{"issue":"11","key":"10.1016\/j.eprac.2025.07.023_bib32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrendo.2015.155","article-title":"Scope and limitations of iodothyronine deiodinases in hypothyroidism","volume":"11","author":"Gereben","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2025.07.023_bib33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jama.299.7.769","article-title":"Triiodothyronine levels in athyreotic individuals during levothyroxine therapy","volume":"299","author":"Jonklaas","year":"2008","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.eprac.2025.07.023_bib34","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"American Thyroid Association Task Force on Thyroid Hormone Replacement. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2025.07.023_bib35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3389\/fendo.2018.00511","article-title":"A renewed focus on the association between thyroid hormones and lipid metabolism","volume":"9","author":"Duntas","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10.1016\/j.eprac.2025.07.023_bib36","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1089\/thy.2012.0457","article-title":"Decreased expression of hepatic low-density lipoprotein receptor-related protein 1 in hypothyroidism: a novel mechanism of atherogenic dyslipidemia in hypothyroidism","volume":"23","author":"Moon","year":"2013","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.eprac.2025.07.023_bib37","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa672","article-title":"Treatment of thyroid dysfunction and serum lipids: a systematic review and meta-analysis","volume":"105","author":"Kotwal","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2025.07.023_bib38","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/thy.2023.0169","article-title":"Thyroid stimulating hormone and thyroid hormones (triiodothyronine and thyroxine): an American thyroid association-commissioned review of current clinical and laboratory status","volume":"33","author":"Van Uytfanghe","year":"2023","journal-title":"Thyroid"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:29:54Z","timestamp":1772890194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25009930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1530891X25009930"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.07.023","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower Serum Triiodothyronine Levels Constitute an Independent Risk Factor for Dyslipidemia in Levothyroxin-Treated Patients","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}